Benefits of capillary glucose monitoring systems outweigh the risks despite erroneous results |
Journal Updates
eMediNexus Coverage from: 
Benefits of capillary glucose monitoring systems outweigh the risks despite erroneous results

8 Read Comments                

A US Food and Drug Administration (FDA) advisory committee says that the benefits of blood glucose monitoring systems that use capillary samples may outweigh risks for any adverse events due to an error in the result, despite chances of erroneous results as compared to the results obtained with arterial or venous samples.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now